2021年最新SCI期刊影响因子查询系统
VIRCHOWS ARCHIV 期刊详细信息
基本信息
期刊名称 | VIRCHOWS ARCHIV VIRCHOWS ARCHIV |
---|---|
期刊ISSN | 0945-6317 |
期刊官方网站 | http://www.springer.com/medicine/pathology/journal/428 |
是否OA | 否 |
出版商 | Springer Verlag |
出版周期 | Monthly |
始发年份 | 1994 |
年文章数 | 183 |
最新影响因子 | 4.535(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | PATHOLOGY 病理学3区 | 否 | 否 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 2.52 | 1.137 | 0.951 |
Medicine Pathology and Forensic Medicine |
40 / 184 | 78% |
|||
Biochemistry, Genetics and Molecular Biology Cell Biology |
153 / 265 | 42% |
|||
Biochemistry, Genetics and Molecular Biology Molecular Biology |
204 / 375 | 45% |
补充信息
自引率 | 4.80% |
---|---|
H-index | 90 |
SCI收录状况 |
Science Citation Index
Science Citation Index Expanded |
官方审稿时间 | Submission to first decision 28 days |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0945-6317%5BISSN%5D |
投稿指南
期刊投稿网址 | https://www.editorialmanager.com/viar |
---|---|
收稿范围 | The Official Journal of the European Society of Pathology Mission statement: To advance the scientific basis of human pathology by the publication (encouragement and dissemination) of high quality research (including molecular and translational studies) and thereby contribute to patient care. Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |